The Triangle Business Journal (Free subscription) | 14 hours ago
The top brass of Swiss drug maker Novartis AG is expected to be in Holly Springs this afternoon at a ribbon-cutting ceremony for a $1.2 billion facility that will be the first in the United States to use a new cell-culture technology to produce flu vaccines. (NVS)
Chicago Tribune (Free subscription) | 18 hours ago
BASEL, Switzerland Swiss pharmaceuticals maker Novartis AG has opened the first U.S. plant to produce flu vaccines using cell cultures instead of egg-based methods, it said Tuesday.
Jim Cramer's Mad Money (Free subscription) | yesterday
Jim Cramer’s Mad Money Stock Picks for Monday November 23 2009. These are all of Jim Cramer’s stock picks that are a Buy! I bold my picks. Buy: Stanley Works (SWK) Masco (MAS) Black & Decker (BDK) Home Depot (HD) Sanofi-Aventis (SNY) CIENA (CIEN) Whirlpool (WHR) Verizon (VZ) AT&T (T) Amazon.com (AMZN) Nordic American Tanker (NAT) Sell: Vimpel Communications (VIP) Novartis AG (NVS)...
Click here to see all comments
MAXIDEX DEXAMETHASONE WARNING
I had eye surgery and in the post-op pack was MAXIDEX(dexamethasone) drops by ALCON LABS. Two days later I was BLIND Use Google and enter EPOCRATES...
Madd Money (Free subscription) | yesterday
Bullish Verizon Communications (VZ), AT&T Inc. (T), Sanofi-Aventis SA (ADR)(NYSE:SNY) and CIENA Corp. (CIEN). Bearish Vimpel Communications (ADR)(NYSE:VIP) and Novartis AG (NVS). Join the fastest growing community of small cap investors at Stockhideout.com
Click here to see all comments
MAXIDEX DEXAMETHASONE WARNING
I had eye surgery and in the post-op pack was MAXIDEX(dexamethasone) drops by ALCON LABS. Two days later I was BLIND Use Google and enter EPOCRATES...
Miami Herald (Free subscription) | 11/17/2009
Pharmaceutical maker Novartis AG said Tuesday a U.S. clinical study suggests that half a dose of its swine flu vaccine may be sufficient to protect people from the virus and could allow many more to be immunized with current supplies.
Health - The Post Chronicle (Free subscription) | 11/17/2009
A U.S. clinical study suggests that just half a dose of the Novartis AG H1N1 vaccine may be enough to generate a protective immune response, the Swiss drugmaker said on Tuesday....
Boston Globe (Free subscription) | 11/13/2009
Swiss pharmaceutical company Novartis AG said Friday it has received regulatory approval in Switzerland for a swine flu vaccine produced using cell cultures instead of egg-based methods.
Miami Herald (Free subscription) | 11/13/2009
Serbia's health authorities have ordered three million swine flu vaccines from Swiss pharmaceutical company Novartis AG worth an estimated euro24 million ($36 million).
San Fransisco Chronicle (Free subscription) | 11/13/2009
Serbia's health authorities have ordered three million swine flu vaccines from Swiss pharmaceutical company Novartis AG worth an estimated euro24 million ($36 million). Health officials said Friday the first shipment of some 500,000 doses is to arrive next... Swine influenza - Vaccine - Novartis - Serbia - Pharmaceutical industry
Seattle Post-Intelligencer (Free subscription) | 11/13/2009
BELGRADE, Serbia -- Serbia's health authorities have ordered three million swine flu vaccines from Swiss pharmaceutical company Novartis AG worth an estimated euro24 million ($36 million).
Seattle Times (Free subscription) | 11/13/2009
Serbia's health authorities have ordered three million swine flu vaccines from Swiss pharmaceutical company Novartis AG worth an estimated euro24 million ($36 million).
Boston Globe (Free subscription) | 11/13/2009
Serbia's health authorities have ordered three million swine flu vaccines from Swiss pharmaceutical company Novartis AG worth an estimated euro24 million ($36 million).
MarketIntelligenceCenter.com (Free subscription) | 11/12/2009
Novartis AG (NYSE: NVS) opened at $53.14. So far today, the stock has hit a low of $52.86 and a high of $53.33. NVS is now trading at $52.92, down $0.55 (-1.03%). Over the last 52 weeks the stock has ranged from a low of $33.34 to a high of $53.81. Barclays Capital initiated coverage on NVS today, starting t...
China Hearsay (Free subscription) | 11/04/2009
Swiss drugmaker Novartis AG is investing $1 billion to build the largest pharmaceutical research plant in China, emphasising the importance of developing markets for future growth. Novartis and other drugmakers are keen to tap into markets such as China as they face slowing growth and loss of exclusivity on key products, including the [...]
Market Watch (Free subscription) | 11/04/2009
TEL AVIV (MarketWatch) -- Novartis AG, the Basel health-care giant, said on Wednesday that it definitively agreed to acquire 85% of the closely held Chinese vaccines company Zhejiang Tianyuan Bio-Pharmaceutical Co. for about $125 million cash. The Chinese company produces vaccines targeting a number of viral and bacterial diseases, Novartis said. In 2008, Zhejiang Tianyuan doubled its net sales from...
The 2 latest articles published by users on Novartis AG :
obi jo | 07/27/2009
http://benkazie.wordpress.com/2009/07/27/quick-post-panel-urges-fda-to-expedite-swine-flu-vaccine-approval/ US Global health officials are scrambling to try to prevent the spread of the H1N1 swine flu virus, with US officials moving Thursday with a recommendation that the Food and Drug Administration approve or license a vaccine. A federal advisory panel said the FDA should move ahead to approve or
ravjen | 06/14/2009
Swine flu vaccine successfully produced weeks ahead of expectations of the Swiss pharmaceutical company Novartis AG . The vaccine was made in cells, rather than grown in eggs as is usually the case with vaccines.
Videos